EU Clinical Trials Register in co-operation with WHO
Information contained in the European Union (EU) Clinical Trials Register managed by the European Medicines Agency EMA is now also available through the WHO International Clinical Trial Registry Platform (ICTRP).
This follows recognition by the World Health Organization (WHO) in September 2011 of the EU Clinical Trials Register as one of the 'primary registries' for the ICTRP. The WHO and EMA have worked together in developing the technical processes to allow data transfer from the EU Clinical Trials Register to ICTRP.
ICTRP is a web-based portal that allows access to a wide range of information from different clinical-trial registers from across the world. Primary registries meet specific criteria for content, quality, validity and transparency. Recognition as a primary registry is an endorsement of the importance of the EU Clinical Trials Register for potential clinical trial participants as well as sponsors, researchers, ethics committees and policymakers.
The availability of the register on the WHO ICTRP platform provides wider access to the information contained in the registry and contributes to the dissemination of information related to authorised clinical trials for use by the scientific community and the public.
Source: EMA Press Release
Related GMP News
17.10.2024FDA's final Q&A Document on Electronic Systems & Data in Clinical Trials
17.10.2024EMA Guideline on Quality and Equivalence of Topical Products
05.09.2024Clinical Trials Regulation - Version 6.9 of the Q&As
23.07.2024Pilot Results on Regulatory-Led RWE Generation
23.07.2024ICH M12 Guideline on Drug Interaction Studies
20.06.2024Draft ICH M14 Guideline on Real-World Data for Safety Assessment